185 related articles for article (PubMed ID: 15178736)
1. Amantadine in the akinetic-rigid variant of Huntington's disease.
Magnet MK; Bonelli RM; Kapfhammer HP
Ann Pharmacother; 2004; 38(7-8):1194-6. PubMed ID: 15178736
[TBL] [Abstract][Full Text] [Related]
2. Amantadine in Huntington's disease: open-label video-blinded study.
Lucetti C; Gambaccini G; Bernardini S; Dell'Agnello G; Petrozzi L; Rossi G; Bonuccelli U
Neurol Sci; 2002 Sep; 23 Suppl 2():S83-4. PubMed ID: 12548355
[TBL] [Abstract][Full Text] [Related]
3. Amantadine in Parkinson's disease: pro and contra.
Greulich W; Fenger E
J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
[TBL] [Abstract][Full Text] [Related]
4. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
[TBL] [Abstract][Full Text] [Related]
5. Twenty-five years of amantadine therapy in Parkinson's disease.
Danielczyk W
J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
[TBL] [Abstract][Full Text] [Related]
6. Zotepine in Huntington's disease.
Bonelli RM; Niederwieser G; Lahousen T; Hofmann P
Hum Psychopharmacol; 2003 Apr; 18(3):227-9. PubMed ID: 12672176
[TBL] [Abstract][Full Text] [Related]
7. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE
BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108
[TBL] [Abstract][Full Text] [Related]
9. Levodopa responsive parkinsonism in an adult with Huntington's disease.
Racette BA; Perlmutter JS
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):577-9. PubMed ID: 9771791
[TBL] [Abstract][Full Text] [Related]
10. Association between amantadine and the onset of dementia in Parkinson's disease.
Inzelberg R; Bonuccelli U; Schechtman E; Miniowich A; Strugatsky R; Ceravolo R; Logi C; Rossi C; Klein C; Rabey JM
Mov Disord; 2006 Sep; 21(9):1375-9. PubMed ID: 16705684
[TBL] [Abstract][Full Text] [Related]
11. Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
Nissenkorn A; Hassin-Baer S; Lerman SF; Levi YB; Tzadok M; Ben-Zeev B
J Child Neurol; 2013 Feb; 28(2):155-60. PubMed ID: 22550086
[TBL] [Abstract][Full Text] [Related]
12. Amantadine in Huntington's chorea.
Weiner WJ; Klawans HL
N Engl J Med; 1972 Jan; 286(2):106. PubMed ID: 4256208
[No Abstract] [Full Text] [Related]
13. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
Kubo S; Iwatake A; Ebihara N; Murakami A; Hattori N
Parkinsonism Relat Disord; 2008; 14(2):166-9. PubMed ID: 17509924
[TBL] [Abstract][Full Text] [Related]
14. Amantadine and Huntington's chorea.
Scotti G; Spinnler H
N Engl J Med; 1971 Dec; 285(23):1325-6. PubMed ID: 4255886
[No Abstract] [Full Text] [Related]
15. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.
Diguet E; Fernagut PO; Wei X; Du Y; Rouland R; Gross C; Bezard E; Tison F
Eur J Neurosci; 2004 Jun; 19(12):3266-76. PubMed ID: 15217383
[TBL] [Abstract][Full Text] [Related]
16. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
[TBL] [Abstract][Full Text] [Related]
17. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
Buchwald B; Angersbach D; Jost WH
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
Saran BM; Klein MS; Benay EM
J Clin Psychiatry; 1980 Jun; 41(6):221. PubMed ID: 6445900
[No Abstract] [Full Text] [Related]
19. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
20. Juvenile Huntington's disease: a case report and literature review.
Reyes Molón L; Yáñez Sáez RM; López-Ibor Alcocer MI
Actas Esp Psiquiatr; 2010; 38(5):285-94. PubMed ID: 21117003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]